Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

French JA, Cole AJ, Faught E, Theodore WH, et al. Safety and Efficacy of Nataluzimab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study. Neurology 2021 Sep 14. pii: WNL.0000000000012766.
PMID: 34521687


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016